Alnylam's RNAi Failure Could Catch Monsanto Investors Off Guard
Image source: Getty Images. The Nobel Prize made headlines on two occasions this week, albeit for very different reasons. As a handful of scientists across the globe joined an exclusive club of laureates, the technology awarded the Nobel Prize in Physiology or Medicine in 2006 suffered a devastating setback. On Wednesday evening Alnylam Pharmaceuticals (NASDAQ:… Read More »